Nomura Holdings, Inc. (NMR) 

Investigation 

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nomura Holdings, Inc. ("Nomura" or "the Company") (NYSE: NMR). The investigation concerns whether Nomura and certain of its officers and/or directors have violated federal securities laws.

 

On March 29, 2021, Nomura disclosed that it anticipated significant losses in connection with positions linked to Archegos Capital Management (“Archegos”) after Archegos failed to meet margin calls the prior week, forcing the liquidation of more than $20 billion in holdings.  That same day, Bloomberg reported that “[m]uch of the leverage used by [Archegos] was provided by banks including Nomura Holdings Inc. and Credit Suisse Group AG through swaps and so-called contracts for difference[.]”  On this news, Nomura’s stock price fell $0.93 per share, or 14.07%, to close at $5.68 per share on March 29, 2021.

 

If you are aware of any facts relating to this investigation, or purchased Nomura shares, you can assist this investigation by visiting contacting the firm. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

© 2020 Bronstein, Gewirtz & Grossman, LLC

  • Twitter Social Icon
  • LinkedIn

BG&G is not affiliated to any of these companies. All respective trademarks are owned by the respective companies.